![5α-Reductase inhibitors alter steroid metabolism and may contribute to insulin resistance, diabetes, metabolic syndrome and vascular disease: a medical hypothesis 5α-Reductase inhibitors alter steroid metabolism and may contribute to insulin resistance, diabetes, metabolic syndrome and vascular disease: a medical hypothesis](https://www.degruyter.com/document/doi/10.1515/hmbci-2014-0025/asset/graphic/hmbci-2014-0025_fig1.jpg)
5α-Reductase inhibitors alter steroid metabolism and may contribute to insulin resistance, diabetes, metabolic syndrome and vascular disease: a medical hypothesis
![Cosmetics | Free Full-Text | Sulforaphane, L-Menthol, and Dexpanthenol as a Novel Active Cosmetic Ingredient Composition for Relieving Hair Loss Symptoms Cosmetics | Free Full-Text | Sulforaphane, L-Menthol, and Dexpanthenol as a Novel Active Cosmetic Ingredient Composition for Relieving Hair Loss Symptoms](https://www.mdpi.com/cosmetics/cosmetics-08-00063/article_deploy/html/images/cosmetics-08-00063-g001.png)
Cosmetics | Free Full-Text | Sulforaphane, L-Menthol, and Dexpanthenol as a Novel Active Cosmetic Ingredient Composition for Relieving Hair Loss Symptoms
![Mechanism-Based Inhibition of Human Steroid 5α-Reductase by Finasteride: Enzyme-Catalyzed Formation of NADP−Dihydrofinasteride, a Potent Bisubstrate Analog Inhibitor | Journal of the American Chemical Society Mechanism-Based Inhibition of Human Steroid 5α-Reductase by Finasteride: Enzyme-Catalyzed Formation of NADP−Dihydrofinasteride, a Potent Bisubstrate Analog Inhibitor | Journal of the American Chemical Society](https://pubs.acs.org/cms/10.1021/ja953069t/asset/images/medium/ja953069tfc05a.gif)
Mechanism-Based Inhibition of Human Steroid 5α-Reductase by Finasteride: Enzyme-Catalyzed Formation of NADP−Dihydrofinasteride, a Potent Bisubstrate Analog Inhibitor | Journal of the American Chemical Society
![Table 5 from Outcomes and quality of life issues in the pharmacological management of benign prostatic hyperplasia (BPH) | Semantic Scholar Table 5 from Outcomes and quality of life issues in the pharmacological management of benign prostatic hyperplasia (BPH) | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/80402227e6af77af74a91ad845d4f6f966d4e610/8-Table4-1.png)
Table 5 from Outcomes and quality of life issues in the pharmacological management of benign prostatic hyperplasia (BPH) | Semantic Scholar
![Early embryonic exposure of freshwater gastropods to pharmaceutical 5-alpha-reductase inhibitors results in a surprising open-coiled “banana-shaped” shell | Scientific Reports Early embryonic exposure of freshwater gastropods to pharmaceutical 5-alpha-reductase inhibitors results in a surprising open-coiled “banana-shaped” shell | Scientific Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-019-52850-x/MediaObjects/41598_2019_52850_Fig1_HTML.png)
Early embryonic exposure of freshwater gastropods to pharmaceutical 5-alpha-reductase inhibitors results in a surprising open-coiled “banana-shaped” shell | Scientific Reports
![Persistent erectile dysfunction in men exposed to the 5α-reductase inhibitors, finasteride, or dutasteride [PeerJ] Persistent erectile dysfunction in men exposed to the 5α-reductase inhibitors, finasteride, or dutasteride [PeerJ]](https://dfzljdn9uc3pi.cloudfront.net/2017/3020/1/fig-1-full.png)
Persistent erectile dysfunction in men exposed to the 5α-reductase inhibitors, finasteride, or dutasteride [PeerJ]
![In Vitro and In Vivo Skin Distribution of 5α-Reductase Inhibitors Loaded Into Liquid Crystalline Nanoparticles - Journal of Pharmaceutical Sciences In Vitro and In Vivo Skin Distribution of 5α-Reductase Inhibitors Loaded Into Liquid Crystalline Nanoparticles - Journal of Pharmaceutical Sciences](https://jpharmsci.org/cms/attachment/6d1e8498-1d05-47ea-b1af-039daf12e6fb/gr1.jpg)
In Vitro and In Vivo Skin Distribution of 5α-Reductase Inhibitors Loaded Into Liquid Crystalline Nanoparticles - Journal of Pharmaceutical Sciences
![5α-reductase inhibitors in benign prostatic hyperplasia and prostate cancer risk reduction - ScienceDirect 5α-reductase inhibitors in benign prostatic hyperplasia and prostate cancer risk reduction - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1521690X08000286-gr1.jpg)
5α-reductase inhibitors in benign prostatic hyperplasia and prostate cancer risk reduction - ScienceDirect
![Structure of human steroid 5α-reductase 2 with the anti-androgen drug finasteride | Nature Communications Structure of human steroid 5α-reductase 2 with the anti-androgen drug finasteride | Nature Communications](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41467-020-19249-z/MediaObjects/41467_2020_19249_Fig1_HTML.png)
Structure of human steroid 5α-reductase 2 with the anti-androgen drug finasteride | Nature Communications
![Structure and mechanism of action of finasteride, a 5-alpha reductase... | Download Scientific Diagram Structure and mechanism of action of finasteride, a 5-alpha reductase... | Download Scientific Diagram](https://www.researchgate.net/publication/333823673/figure/fig1/AS:770772205305858@1560777822658/Structure-and-mechanism-of-action-of-finasteride-a-5-alpha-reductase-inhibitor-reduces.png)